Česká republika - čeština - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

livisto int'l, s.l. - prednisolon - tableta - glukokortikoidy - psi

Česká republika - čeština - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

livisto int'l, s.l. - prednisolon - tableta - glukokortikoidy - psi, kočky

Evropská unie - čeština - EMA (European Medicines Agency)

diurnal europe b.v. - hydrokortison - nedostatek adrenalinu - kortikosteroidy pro systémové použití - substituční léčba adrenální insuficience u kojenců, dětí a dospívajících (od narození do < 18 let).

Evropská unie - čeština - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cobicistat, atazanavir - hiv infekce - antivirotika pro systémové použití - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 a 5.

Evropská unie - čeština - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - thalidomid - mnohočetný myelom - imunosupresiva - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Evropská unie - čeština - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydrochlorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresiva - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Evropská unie - čeština - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - azacitidin - leukemie, myeloidní, akutní - antineoplastická činidla - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Evropská unie - čeština - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - ostatní srdeční přípravky - treatment of symptomatic obstructive hypertrophic cardiomyopathy.

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

dr. august wolff gmbh & co. kg arzneimittel, bielefeld array - 13226 hemihydrÁt estradiolu - vaginální krém - 0,01g/100g - estradiol

Evropská unie - čeština - EMA (European Medicines Agency)

diurnal europe b.v. - hydrokortison - adrenal hyperplasia, congenital - kortikosteroidy pro systémové použití - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.